Global HealthTech Unicorns

A unicorn startup or unicorn company is a private company with a valuation over $1 billion USD. Unicorns are ‘startups’, i.e they do not include post-exit, acquired or listed companies, nor do they include ‘mature’ incumbents.

As of 30 May 2022, there are 93 HealthTech Unicorns around the world who are now collectively valued at $228B.

Reify Health, Oura, Clarify Health, IntelyCare, NexHealth, BostonGene and Biofourmis joined the list in Apr 2022.

BenevolentAI left the list in Apr 2022 via SPAC.

Somatus and Omada Health joined the list in Feb 2022.

Saliogen Therapeutics, Athelas, Athletic Greens and Transcarent joined the list in Jan 2022.

Pristyn Care and Cadence Solutions joined the list in Dec 2021.

EQRx left the list in Dec 2021 via IPO.

Pear Therapeutics was acquired by Thimble Point (SPAC) in Dec 2021.

Abogen, SWORD Health, Curefit and Papa joined the list in Nov 2021.

Elemy, Dental Monitoring, and Truepill joined the list in Oct 2021.

VillageMD was acquired by Walgreens Boots Alliance in Oct 2021.

Babylon Health and Oxford Nanopore Technologies left the list in Oct 2021 via IPO.

Spring Health, Mammoth Biosciences and TrialSpark joined the list in Sep 2021.

Ginkgo BioWorks left the list in Sep 2021 via IPO.

Maven Clinic joined the list in Aug 2021.

Grail was acquired by Illumina in Aug 2021.

Rani Therapeutics, Lyell Immunopharma and Brii Biosciences left the list in Jul 2021 via IPO.

PharmEasy, Prime Medicine, Cerebral, SonderMind, Carbon Health, Yaoshibang and dMed Biopharmaceutical joined the list in Jun – Jul 2021.

ATAI Life Sciences and Bright Health left the list in Jun 2021 via IPO.

Roivant Sciences left the list in May 2021 via IPO.

Capsule, KRY, Caris Life Sciences, Collective Health, Noom, Valgen Medtech, Fiture joined the list in Apr – May 2021.

Outcome Health was acquired by PatientPoint in Mar 2021.

Aledade, EQRx, Innovaccer, ATAI Life Sciences, Brii BioSciences, Evidation Health, Ginger, Komodo Health, Radiology Partners, Rightway, Unite Us, DispatchHealth, Pear Therapeutics, Insitro and Shulan Health joined the list in Jan – Mar 2021.

Recursion Pharmaceuticals left the list in Apr 2021 via IPO.

Oscar Health left the list in Mar 2021 via IPO.

Sema4 was acquired by Casdin Capital and Corvex Management (SPAC) in Feb 2021.

23andMe was acquired by Virgin Galactic Acquisition Corporation (SPAC) in Feb 2021.

Clover Health left the list in Jan 2021 via IPO.